Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
macrolides berotralstat

increases exposure

Unknown Study
macrolides betablockers,non-selective

increases exposure

Unknown Study
macrolides chloroquine

increases risk of seriouscardiovascularadverseeffects

Unknown Theoretical
macrolides hydroxychloroquine

increases risk of seriouscardiovascularadverseeffects

Unknown Theoretical
macrolides insulin

increases risk of severehypoglycaemia

Unknown Theoretical
macrolides nadolol

increases exposure

Unknown Study
macrolides nintedanib

increases exposure

Unknown Study
macrolides pibrentasvir

increases exposure

Unknown Theoretical
macrolides relugolix

increases exposure

Unknown Study
macrolides sulfonylureas

increases exposure

Unknown Theoretical
macrolides tigecycline

increases exposure

Unknown Anecdotal
macrolides topotecan

increases exposure

Unknown Study
macrolides trametinib

increases concentration

Unknown Theoretical
macrolides vincaalkaloids

increases exposure

Unknown Theoretical
macrolidesgivenwithapotentcyp2c19 inhibitor tofacitinib

increases exposure

Unknown Study
magnesium roxadustat

decreases exposure

Unknown Theoretical
mao-binhibitors amfetamines

increases risk of severehypertension

Unknown Theoretical
mao-binhibitors linezolid

increases risk of adverseeffects

Unknown Theoretical
maois,irreversible atomoxetine

increases risk of adverseeffects

Unknown Theoretical
maois,irreversible beta

increases risk of cardiovascularadverseeffects

Unknown Anecdotal
maois,irreversible doxapram

increases effects

Unknown Theoretical
maois,irreversible linezolid

increases risk of adverseeffects

Unknown Theoretical
maois,irreversible phenothiazines

increases risk of neurolepticmalignantsyndrome

Unknown Theoretical
maois,irreversible rizatriptan

increases exposure

Unknown Theoretical
maois,irreversible sumatriptan

increases exposure

Unknown Theoretical
maois,irreversible triptans

increases exposure

Unknown Theoretical
maois,irreversible zolmitriptan

increases exposure

Unknown Theoretical
mefloquine betablockers,non-selective

increases risk of bradycardia

Unknown Theoretical
mefloquine betablockers,selective

increases risk of bradycardia

Unknown Theoretical
mefloquine calciumchannelblockers

increases risk of bradycardia

Unknown Theoretical
mefloquine digoxin

increases risk of bradycardia

Unknown Theoretical
memantine apomorphine

increases effects

Unknown Theoretical
memantine bromocriptine

increases effects

Unknown Theoretical
memantine cabergoline

increases effects

Unknown Theoretical
memantine dopaminereceptoragonists

increases effects

Unknown Theoretical
memantine levodopa

increases effects

Unknown Theoretical
memantine pramipexole

increases effects

Unknown Theoretical
memantine quinagolide

increases effects

Unknown Theoretical
memantine ropinirole

increases effects

Unknown Theoretical
memantine rotigotine

increases effects

Unknown Theoretical
mercaptopurine coumarins

decreases anticoagulant effect

Unknown Anecdotal
methotrexate sapropterin

decreases efficacy

Unknown Theoretical
methotrexate topicalfluorouracil

increases risk of severeskinreaction

Unknown Anecdotal
methylphenidate ozanimod

increases risk of ahypertensivecrisis

Unknown Theoretical
methylphenidate volatilehalogenatedanaesthetics

increases risk of hypertensionandarrhythmias

Unknown Theoretical
metoclopramide antifungals,azoles

decreases absorption

Unknown Study
metoclopramide apomorphine

decreases effects

Unknown Study
metoclopramide atovaquone

decreases concentration

Unknown Study
metoclopramide bromocriptine

decreases effects

Unknown Study
metoclopramide cabergoline

decreases effects

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.